We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.04B
AUM Growth
-$134M
Cap. Flow
-$160M
Cap. Flow %
-15.32%
Top 10 Hldgs %
17.93%
Holding
1,138
New
391
Increased
229
Reduced
281
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Financials 13.67%
3 Healthcare 9.75%
4 Industrials 9.11%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIO icon
851
Fortress Biotech
FBIO
$91.7M
$5K ﹤0.01%
+120
New +$4.49K
KYNB
852
Kyntra Bio
KYNB
$28.1M
$5K ﹤0.01%
+9
New +$4.49K
GOGO icon
853
Gogo Inc
GOGO
$479M
$5K ﹤0.01%
+490
New +$4.84K
HRTX icon
854
Heron Therapeutics
HRTX
$94.2M
$5K ﹤0.01%
+399
New +$6.26K
INO icon
855
Inovio Pharmaceuticals
INO
$69.4M
$5K ﹤0.01%
+66
New +$5.97K
NTLA icon
856
Intellia Therapeutics
NTLA
$1.56B
$5K ﹤0.01%
+387
New +$5.81K
OMER icon
857
Omeros
OMER
$923M
$5K ﹤0.01%
+465
New +$4.75K
RCKT icon
858
Rocket Pharmaceuticals
RCKT
$389M
$5K ﹤0.01%
+200
New +$5.71K
TSQ icon
859
Townsquare Media
TSQ
$113M
$5K ﹤0.01%
+510
New +$4.71K
VLGEA icon
860
Village Super Market
VLGEA
$641M
$5K ﹤0.01%
+146
New +$4.74K
AVGR
861
DELISTED
Avinger, Inc. Common Stock
AVGR
0
BPTH
862
DELISTED
Bio-Path Holdings Inc
BPTH
$5K ﹤0.01%
+1
New +$4.84K
AGRX
863
DELISTED
Agile Therapeutics
AGRX
0
HMTV
864
DELISTED
Hemisphere Media Group, Inc.
HMTV
$5K ﹤0.01%
+434
New +$5.12K
ACIA
865
DELISTED
Acacia Communications Inc
ACIA
$5K ﹤0.01%
+76
New +$5.79K
CBMG
866
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$5K ﹤0.01%
+354
New +$4.74K
GNC
867
DELISTED
GNC Holdings, Inc.
GNC
$5K ﹤0.01%
+423
New +$6.62K
CVRS
868
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$5K ﹤0.01%
+6,675
New +$5.62K
PERY
869
DELISTED
Perry Ellis International Inc
PERY
$5K ﹤0.01%
+201
New +$4.5K
NVIV
870
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
0
MACK
871
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$5K ﹤0.01%
+156
New +$6.65K
FNBC
872
DELISTED
First NBC Bank Holding Company
FNBC
$5K ﹤0.01%
+671
New +$5.3K
BBOX
873
DELISTED
Black Box Corp
BBOX
$5K ﹤0.01%
+311
New +$4.46K
AXSM icon
874
Axsome Therapeutics
AXSM
$11B
$4K ﹤0.01%
+600
New +$4.21K
GTN icon
875
Gray Television
GTN
$458M
$4K ﹤0.01%
+400
New +$3.93K

Similar funds

Meeder Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Meeder Asset Management held 1,138 positions worth $1.04B, down 11% from $1.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management withdrew a net $160M in Q4 2016, closing 148 positions and reducing 281 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $74.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in iShares Core US Aggregate Bond ETF worth $17.1M.

  • Meeder Asset Management's largest Q4 2016 buy was iShares Core US Aggregate Bond ETF: 157,897 shares worth $17.1M.
  • Meeder Asset Management added most to Time Warner Inc in Q4 2016, an estimated $4.76M increase.
  • Meeder Asset Management's biggest Q4 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $43.5M.
  • Meeder Asset Management fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $74.7M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.04B portfolio in Q4 2016.
  • Meeder Asset Management opened 391 new positions and closed 148 in Q4 2016.
  • Meeder Asset Management's portfolio value fell 11% quarter-over-quarter to $1.04B.

Based on Meeder Asset Management's 13F filing for Q4 2016, filed 11 Jan 2017.